SCOPUS 정보 검색 플랫폼

Volumn 85, Issue 1, 2002, Pages 89-94

Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix

(10) Fiorica, J a Holloway, R b Ndubisi, B c Orr, J d Grendys, E a Boothby, R e DeCesare, S f LaPolla, J g Hoffman, M h Patel, J i

a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE (United States)

b FLORIDA HOSPITAL (United States)

c USA (United States)

d Patty Berg Cancer Center (United States)

e M D ANDERSON CANCER CENTER ORLANDO (United States)

f UNIVERSITY OF FLORIDA (United States)

g Bayfront Med Center St Petersburg (United States)

h Watson Clinic (United States)

i GLAXOSMITHKLINE (United States)

Author keywords

Cisplatin; Nonsquamous cell carcinoma of the cervix; Platinum based chemotherapy; Recurrent; Squamous cell carcinoma of the cervix; Topotecan

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GRANULOCYTE COLONY STIMULATING FACTOR; TOPOTECAN;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; FEMALE; GYNECOLOGIC CANCER; HUMAN; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0036227178 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2001.6557 Document Type: Article

Times cited : (61)

References (26)

1
- 0035114558
- Cancer statistics, 2001
- (2001) CA Cancer J Clin , vol.51 , pp. 15-36
- Greenlee, R.T.¹ Hill-Harmon, M.B.² Murray, T.³ Thun, M.⁴

2
- 0033006836
- Cancer statistics, 1999
- (1999) CA Cancer J Clin , vol.49 , pp. 8-31
- Landis, S.H.¹ Murray, T.² Bolden, S.³ Wingo, P.A.⁴

3
- 0035147080
- Intent-to-treat analysis of stage Ib and IIa cervical cancer in the United States: Radiotherapy or surgery 1988-1995
- (2001) Obstet Gynecol , vol.97 , pp. 248-254
- Brewster, W.R.¹ Monk, B.J.² Ziogas, A.³ Anton-Culver, H.⁴ Yamada, S.D.⁵ Berman, M.L.⁶

4
- 0034220270
- Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix
- (2000) Changgeng Yi Xue Za Zhi , vol.23 , pp. 396-404
- Hong, J.H.¹ Tsai, C.S.² Wang, C.C.³ Lai, C.H.⁴ Chen, W.C.⁵ Lee, S.P.⁶ Chang, T.C.⁷ Tseng, C.J.⁸

5
- 0021793908
- Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: A Gynecologic Oncology Group study
- (1985) J Clin Oncol , vol.3 , pp. 1079-1085
- Bonomi, P.¹ Blessing, J.A.² Stehman, F.B.³ DiSaia, P.J.⁴ Walton, L.⁵ Major, F.J.⁶

6
- 0025903822
- Cisplatin in advanced cancer of the cervix: An update
- (1991) Semin Oncol , vol.18 , Issue.SUPPL. 3 , pp. 11-24
- Alberts, D.S.¹ Garcia, D.² Mason-Liddil, N.³

7
- 0033995249
- Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group study
- (2000) J Clin Oncol , vol.18 , pp. 1062-1067
- McGuire, W.P.¹ Blessing, J.A.² Bookman, M.A.³ Lentz, S.S.⁴ Dunton, C.J.⁵

8
- 0031064224
- Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma
- (1997) Semin Oncol , vol.24 , Issue.SUPPL. 5
- Ten Bokkel Huinink, W.¹ Carmichael, J.² Armstrong, D.³ Gordon, A.⁴ Malfetano, J.⁵

9
- 0031786482
- Topotecan for the treatment of advanced epithelial ovarian cancer: An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel
- (1998) J Clin Oncol , vol.16 , pp. 3345-3352
- Bookman, M.A.¹ Malmstrom, H.² Bolis, G.³ Gordon, A.⁴ Lissoni, A.⁵ Krebs, J.B.⁶ Fields, S.Z.⁷

10
- 9244247616
- Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma
- (1996) J Clin Oncol , vol.14 , pp. 1552-1557
- Kudelka, A.P.¹ Tresukosol, D.² Edwards, C.L.³ Freedman, R.S.⁴ Levenback, C.⁵ Chantarawiroj, P.⁶ Gonzalez de Leon, C.⁷ Kim, E.E.⁸ Madden, T.⁹ Wallin, B.¹⁰ Hord, M.¹¹ Verschraegen, C.¹² Raber, M.¹³ Kavanagh, J.J.¹⁴

11
- 0031239998
- Topotecan in platinum- and paclitaxel-resistant ovarian cancer
- doi: 10.1006/gyno.1977.4787
- (1997) Gynecol Oncol , vol.66 , pp. 480-486
- Swisher, E.M.¹ Mutch, D.G.² Rader, J.S.³ Elbendary, A.⁴ Herzog, T.J.⁵

12
- 0031905299
- In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems
- (1998) Cancer Chemother Pharmacol , vol.41 , pp. 385-390
- Romanelli, S.¹ Perego, P.² Pratesi, G.³ Carenini, N.⁴ Tortoreto, M.⁵ Zunino, F.⁶

13
- 0031965435
- Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro
- (1998) Cancer Chemother Pharmacol , vol.41 , pp. 307-316
- Ma, J.¹ Maliepaard, M.² Nooter, K.³ Boersma, A.W.⁴ Verweij, J.⁵ Stoter, G.⁶ Schellens, J.H.⁷

14
- 0028153260
- Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: A rational approach to clinical protocol design
- (1994) J Natl Cancer Inst , vol.86 , pp. 1517-1524
- Chou, T.C.¹ Motzer, R.J.² Tong, Y.³ Bosl, G.J.⁴

15
- 0034089496
- Topotecan in squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
- doi: 10.1006/gyno.2000.5807
- (2000) Gynecol Oncol , vol.77 , pp. 446-449
- Bookman, M.A.¹ Blessing, J.A.² Hanjani, P.³ Herzog, T.J.⁴ Andersen, W.A.⁵

16
- 0000050035
- Phase II trial of topotecan for cervical cancer of the uterus
- Abstract 754
- (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 280
- Noda, K.¹ Sasaki, H.² Yamamoto, K.³ Yamamoto, T.⁴ Nishimura, R.⁵ Sugiyama, T.⁶ Nakajima, H.⁷

17
- 0027999967
- Phase I study of topotecan and cisplatin in patients with advanced solid rumors: A Cancer and Leukemia Group B study
- (1994) J Clin Oncol , vol.12 , pp. 2743-2750
- Miller, A.A.¹ Hargis, J.B.² Lilenbaum, R.C.³ Fields, S.Z.⁴ Rosner, G.L.⁵ Schilsky, R.L.⁶

18
- 0030720766
- Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma
- (1997) Ann Oncol , vol.8 , pp. 1003-1008
- Raymond, E.¹ Burris, H.A.² Rowinsky, E.K.³ Eckardt, J.R.⁴ Rodriguez, G.⁵ Smith, L.⁶ Weiss, G.⁷ Von Hoff, D.D.⁸

19
- 10544249871
- Sequences of topotecan and cisplatin: Phase I, pharmacologic, and in vitro studies to examine sequence dependence
- (1996) J Clin Oncol , vol.14 , pp. 3074-3084
- Rowinsky, E.K.¹ Kaufmann, S.H.² Baker, S.D.³ Grochow, L.B.⁴ Chen, T.-L.⁵ Peereboom, D.⁶ Bowling, M.K.⁷ Sartorius, S.E.⁸ Ettinger, D.S.⁹ Forastiere, A.A.¹⁰ Donehower, R.C.¹¹

20
- 0034671437
- Phase II feasibility study of sequential couplets of cisplatin/topotecan followed by paclitaxel/cisplatin as primary treatment for advanced epithelial ovarian cancer: A National Cancer Institute of Canada Clinical Trials Group study
- (2000) J Clin Oncol , vol.18 , pp. 4038-4044
- Hoskins, P.¹ Eisenhauer, E.² Vergote, I.³ Dubuc-Lissoir, J.⁴ Fisher, B.⁵ Grimshaw, R.⁶ Oza, A.⁷ Plante, M.⁸ Stuart, G.⁹ Vermorken, J.¹⁰

21
- 17144433130
- Phase I pharmacologic study of oral topotecan and intravenous cisplatin: Sequence-dependent hematologic side effects
- (2000) J Clin Oncol , vol.18 , pp. 2104-2115
- De Jonge, M.J.¹ Loos, W.J.² Gelderblom, H.³ Planting, A.S.⁴ Van der Burg, M.E.⁵ Sparreboom, A.⁶ Brouwer, E.⁷ Van Beurden, V.⁸ Mantel, M.A.⁹ Doyle, E.¹⁰ Hearn, S.¹¹ Ross, G.¹² Verweij, J.¹³

22
- 0033789366
- Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin
- (2000) Ann Oncol , vol.11 , pp. 1205-1207
- Gelderblom, A.J.¹ Loos, W.J.² De Jonge, M.J.A.³ Sparreboom, A.⁴ Planting, A.S.T.⁵ Van der Burg, M.E.L.⁶ Brouwer, E.⁷ Verheij, C.⁸ Ouwens, L.⁹ Hearn, S.¹⁰ Verweij, J.¹¹

23
- 0033959650
- Evaluation of gemcitabine in patients with squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group
- doi: 10.1006/gyno.1999.5657
- (2000) Gynecol Oncol , vol.76 , pp. 204-207
- Schilder, R.J.¹ Blessing, J.A.² Morgan, M.³ Mangan, C.E.⁴ Rader, J.S.⁵

24
- 0033957908
- A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix
- doi: 10.1006/gyno.1999.5671
- (2000) Gynecol Oncol , vol.76 , pp. 63-66
- Burnett, A.F.¹ Roman, L.D.² Garcia, A.A.³ Muderspach, L.I.⁴ Brader, K.R.⁵ Morrow, C.P.⁶

25
- 0034517127
- Cellular and molecular responses to topoisomerase I poisons. Exploiting synergy for improved radiotherapy
- (2000) Ann N Y Acad Sci , vol.922 , pp. 274-292
- Miyamoto, S.¹ Huang, T.T.² Wuerzberger-Davis, S.³ Bornmann, W.G.⁴ Pink, J.J.⁵ Tagliarino, C.⁶ Kinsella, T.J.⁷ Boothman, D.A.⁸

26
- 0033875543
- In vivo potentiation of radiation response by topotecan in human rhabdomyosarcoma xenografted into nude mice
- (2000) Clin Cancer Res , vol.6 , pp. 3327-3333
- Chastagner, P.¹ Merlin, J.L.² Marchal, C.³ Hoffstetter, S.⁴ Barberi-Heyob, M.⁵ Vassal, G.⁶ Duprez, A.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.